Empagliflozin in Cardiorenal Syndrome Type 1
1 clinical trials · Condition
◉ Watch Empagliflozin in Cardiorenal Syndrome Type 1
| Record | Firm | Date |
|---|---|---|
| The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1 (NCT06030843) | Chulalongkorn University | 2025-03-01 |
Track Empagliflozin in Cardiorenal Syndrome Type 1 automatically
Every clearance here is in the API, with alerts when new ones post.